2-[5-(2-(4-hydroxyphenyl)ethoxy)-1H-indole-3-yl]ethanamine hydrochloride | 1228827-67-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 2-[5-(2-(4-hydroxyphenyl)ethoxy)-1H-indole-3-yl]ethanamine hydrochloride
• 英文别名: 4-[2-[[3-(2-aminoethyl)-1H-indol-5-yl]oxy]ethyl]phenol;hydrochloride
• CAS: 1228827-67-5
• 化学式: C₁₈H₂₀N₂O₂*ClH
• 分子量: 332.83
• InChiKey: XTGATASWFGEEHE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.42
• 重原子数：
  23
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  71.3
• 氢给体数：
  4
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  tert-butyl 2-{5-[2-(4-(methoxymethoxy)phenyl)ethoxy]-1H-indole-3-yl}ethylcarbamate 在 盐酸 作用下， 以 甲醇 为溶剂， 反应 3.0h， 生成 2-[5-(2-(4-hydroxyphenyl)ethoxy)-1H-indole-3-yl]ethanamine hydrochloride
  参考文献：
  名称：

  Serotonin derivatives as a new class of non-ATP-competitive receptor tyrosine kinase inhibitors

  摘要：

  The discovery of new templates and their subsequent elaboration to clinically useful receptor tyrosine kinase (RTK) inhibitors continues to be an important issue. RTKs are a class of enzymes responsible for the activation of different cellular signal transduction cascades. The majority of the known small molecules RTK inhibitors are ATP-competitive and they are multiple targeted inhibitors. We describe here serotonin derivatives as a new class of multiple targeted RTK inhibitors. In contrast to most other RTK inhibitors they act via a non-ATP-competitive (allosteric) mechanism. Furthermore, they are able to inhibit the proliferation of HUVE cells, fibroblasts and two cancer cell lines. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2010.04.001

文献信息

• Serotonin derivatives as a new class of non-ATP-competitive receptor tyrosine kinase inhibitors
  作者：Anita Büttner、Thomas Cottin、Jing Xu、Lito Tzagkaroulaki、Athanassios Giannis

  DOI：10.1016/j.bmc.2010.04.001

  日期：2010.5

  The discovery of new templates and their subsequent elaboration to clinically useful receptor tyrosine kinase (RTK) inhibitors continues to be an important issue. RTKs are a class of enzymes responsible for the activation of different cellular signal transduction cascades. The majority of the known small molecules RTK inhibitors are ATP-competitive and they are multiple targeted inhibitors. We describe here serotonin derivatives as a new class of multiple targeted RTK inhibitors. In contrast to most other RTK inhibitors they act via a non-ATP-competitive (allosteric) mechanism. Furthermore, they are able to inhibit the proliferation of HUVE cells, fibroblasts and two cancer cell lines. (C) 2010 Elsevier Ltd. All rights reserved.